Publications

The impact of helminths on the response to immunization and on the incidence of infection and disease in childhood in Uganda: design of a randomized, double-blind, placebo-controlled, factorial trial of deworming interventions delivered in pregnancy an...

ELLIOTT, AM; Kizza, M; Quigley, MA; Ndibazza, J; Nampijja, M; Muhangi, L; Morison, L; Namujju, PB; Muwanga, M; Kabatereine, N; WHITWORTH, JA G;

2007

Clinical trials (London, England), (2007).4 1 10.1177/1740774506075248.

Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination.

Lin, MY; Geluk, A; SMITH, SG; Stewart, AL; Friggen, AH; Franken, KL M C; Verduyn, MJ C; Van Meijgaarden, KE; Voskuil, MI; DOCKRELL, HM; Huygen, K; Ottenhoff, TH M; Klein, MR;

2007

Infection and immunity, (2007).75 7 10.1128/IAI.01999-06.

Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study.

Grassly, NC; Wenger, J; Durrani, S; Bahl, S; Deshpande, JM; Sutter, RW; HEYMANN, DL; Aylward, RB;

2007

Lancet, (2007).369 9570 10.1016/S0140-6736(07)60531-5.

Interaction between Bluetongue virus outer capsid protein VP2 and vimentin is necessary for virus egress.

BHATTACHARYA, B; Noad, RJ; ROY, P;

2007

Virology journal, (2007).4 1 10.1186/1743-422X-4-7.

Cost-effectiveness analyses of human papillomavirus vaccination.

Newall, AT; Beutels, P; Wood, JG; EDMUNDS, WJ; MacIntyre, CR;

2007

The Lancet infectious diseases, (2007).7 4 10.1016/S1473-3099(07)70083-X.

The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16M genes.

Commander, NJ; Spencer, SA; WREN, BW; MacMillan, AP;

2007

Vaccine, (2007).25 1 10.1016/j.vaccine.2006.07.046.

New zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months.

Wong, S; Lennon, D; Jackson, C; Stewart, J; Reid, S; Crengle, S; Tilman, S; Aaberge, I; O'Hallahan, J; Oster, P; MULHOLLAND, K; Martin, D;

2007

The Pediatric infectious disease journal, (2007).26 4 10.1097/01.inf.0000258697.05341.2c.

Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthetic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa.

Sirima, SB; Nébié, I; Ouédraogo, A; Tiono, AB; Konaté, AT; Gansané, A; Dermé, AI; Diarra, A; Ouédraogo, A; Soulama, I; Cuzzin-Ouattara, N; COUSENS, S; Leroy, O;

2007

Vaccine, (2007).25 14 10.1016/j.vaccine.2006.05.090.

A challenge for the development of malaria vaccines: polymorphic target antigens.

SUTHERLAND, C;

2007

PLoS medicine, (2007).4 3 10.1371/journal.pmed.0040116.

Effects of sex, parity, and sequence variation on seroreactivity to candidate pregnancy malaria vaccine antigens.

Oleinikov, AV; Rossnagle, E; Francis, S; Mutabingwa, TK; Fried, M; Duffy, PE;

2007

The Journal of infectious diseases, (2007).196 1 10.1086/518513.